Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Non-Current Liabilities: 2019-2025

Historic Total Non-Current Liabilities for Burning Rock Biotech (BNR) over the last 1 years, with Jun 2025 value amounting to $30.6 million.

  • Burning Rock Biotech's Total Non-Current Liabilities was N/A to $30.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $30.6 million, marking a year-over-year change of. This contributed to the annual value of $5.2 million for FY2024, which is 351.64% up from last year.
  • As of Q2 2025, Burning Rock Biotech's Total Non-Current Liabilities stood at $30.6 million, which was up 484.42% from $5.2 million recorded in Q4 2024.
  • In the past 5 years, Burning Rock Biotech's Total Non-Current Liabilities ranged from a high of $30.6 million in Q2 2025 and a low of $1.2 million during Q4 2023.
  • In the last 3 years, Burning Rock Biotech's Total Non-Current Liabilities had a median value of $5.2 million in 2024 and averaged $12.3 million.
  • Per our database at Business Quant, Burning Rock Biotech's Total Non-Current Liabilities surged by 12,682.67% in 2021 and then slumped by 73.27% in 2022.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Total Non-Current Liabilities stood at $9.6 million in 2021, then slumped by 73.27% to $2.6 million in 2022, then tumbled by 54.82% to $1.2 million in 2023, then spiked by 351.64% to $5.2 million in 2024, then reached $30.6 million in 2025.
  • Its last three reported values are $30.6 million in Q2 2025, $5.2 million for Q4 2024, and $1.2 million during Q4 2023.